Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Conjugate Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101056843B reveals a high-yield muscone synthesis route avoiding extreme low temperatures. This breakthrough offers substantial cost reduction and supply chain reliability for fragrance manufacturers.
Patent CN105254657B details a rhodium-catalyzed route for prostaglandin analogs, offering milder conditions and reduced toxicity for reliable supply chain integration.
Patent CN101166708B details a high-yield copper-catalyzed method for (R)-muscone using novel phosphoramidite ligands and enolate scavengers, offering cost-effective scale-up potential.
Patent CN101003504B details an asymmetric synthesis for high-purity prostaglandin intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110054553B details a novel chiral tetrabenzocyclooctatetraene-catalyzed method for high-purity ketone intermediates, offering significant cost and supply chain advantages.
Patent CN112430228B details a novel Rh-catalyzed route for chiral 2,3-dihydrobenzo[b]thiophene 1,1-dioxide, offering superior stereoselectivity and scalable manufacturing for API intermediates.
Novel NHC-Cu catalyzed route for Duloxetine intermediate offers high yield and purity. Cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN101569864B details a novel chiral sulfonamide catalyst enabling high-yield asymmetric conjugate addition, offering a metal-free alternative for pharmaceutical manufacturing.
Patent CN103429567A details a mild Rh-catalyzed process for chiral amino acids with >98% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN101492407B details a mild organocatalytic route for high-purity beta-indolaldehyde, offering significant cost and environmental benefits for pharma manufacturing.